Trial CTSU-A211801


BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation

Type: Prevention
Phase: Phase III
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: Yes
USC Satellite Location: None
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Darcy Spicer, M.D., , , ,
Other Trial Staff:  Mary Ordaz, D.M., Margarita Carranza, D.M., America Casillas-Lopez, Coordinator, Niranjan Bhatt, D.M., Apoorva Vishwanath, D.M., Othesia Glasgow, D.M., Xochitl Quintero, Coordinator, Kimberly Arieli, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.